The prognostic significance of VEGF-C and VEGF-A in non-Hodgkin lymphomas

Leukemia and Lymphoma

Volumn 50, Issue 3, 2009, Pages 366-373

  Paydas, Semra ^a   Seydaoglu, Gulsah ^a   Ergin, Melek ^a   Erdogan, Seyda ^a   Yavuz, Sinan ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

angiogenesis; Hodgkin lymphoma; lymphangiogenesis; Molecular genetics; Neoplasia; Non Hodgkin lymphoma; Prognostication

Indexed keywords

VASCULOTROPIN A; VASCULOTROPIN C;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INVASION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LYMPHANGIOGENESIS; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME; TUMOR VASCULARIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOCRINE COMMUNICATION; FEMALE; HUMANS; LYMPHANGIOGENESIS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTOR CROSS-TALK; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C; YOUNG ADULT;

EID: 67650892411     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190802706665     Document Type: Article

References (55)

1. Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and molecular regulation. Nat Med, 1, pp. 27-31.
2. Beck, L. J. and D'Amore, P. (1997) Vascular development: Cellular and molecular regulation. FASEB J, 11, pp. 365-373.
3. Ellis, I. and Filde, I. (1996) Angiogenesis and metastasis. Eur J Cancer, 32, pp. 2451-2460.
4. Joukov, V., Sorsa, T., Kumar, V., Jeltsch, M., Claesson-Welsh, I. Cao, Y. et al. (1997) Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J, 16, pp. 3898-3911.
5. Franchi, A., Gallo, O., Baroni, G. and Santucci, M. (2004) Tumor lymphangiogenesis in head and neck squamous cell carcinoma. Cancer, 101, pp. 973-978.
6. Mohammed, R AA, Green, A., El-Shikh, S., Paish, E. C., Ellis, I. O. and Martin, S. G. (2007) Prognostic significance of vascular endothelial cell growth factors-A-C- and -D in breast cancer and their relationship with angio- and lymhangiogenesis. Br J Cancer, 96, pp. 1092-1100.
7. Arinaga, M., Noguchi, T., Takeno, S., Chujo, M., Miura, T. and Uchida, Y. (2003) Clinical significance of vascular endothelial growth factor C and non-small cell lung carcinoma. Cancer, 97, pp. 457-464.
8. Nagy, J. A., Vasile, E., Feng, D., Sundberg, C., Brown, L. F. Detmar, M. J. et al. (2002) Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med, 196, pp. 1497-1506.
9. Jeltsch, M., Kaipinen, A., Joukov, V., Meng, X., Lakso, M. Rauvala, H. et al. (1997) Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science, 276, pp. 1423-1425.
10. Salven, P., Orpana, A., Teerenhovi, L. and Joensuu, H. (2000) Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and b FGF is an independent predictor of poor prognosis in non-Hodgkin's lymphoma: A single-institution study of 200 patients. Blood, 96, pp. 3712-3717.
11. Salven, P., Teerenhovi, L. and Joensuu, H. (1997) A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma. Blood, 90, pp. 3167-3172.
12. Moehler, T. M., Ho, A. D., Golschmidt, H. and Barlogie, B. (2003) Angiogenesis in hematologic malignancies. Crit Rev Oncol Hematol, 45, pp. 227-244.
13. Rajkumar, S. V., Leong, T., Roche, P. C., Fonseca, R., Dipenzieri, A. Lacy, M. Q. et al. (2000) Prognostic value of bone marrow angiogenesis in multiple myeloma. Clin Cancer Res, 6, pp. 3111-3116.
14. Vacca, A., Ribatti, D., Ruco, L., Giacchetta, F., Nico, B. Quondamatteo, F. et al. (1999) Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphoma. Br J Cancer, 79, pp. 965-970.
15. Salven, P. (2001) Angiogenesis in lymphoproliferative disorders. Acta Haematol, 106, pp. 184-189.
16. Giles, F. J., Vose, J. M., Do, K. A., Johnson, M. M., Manshouri, T. Bociek, G. et al. (2004) Clinical relevance o circulating angiogenic factors in patients with non-Hodgkin's lymphoma. Leuk Res, 28, pp. 595-604.
17. Hoss, H. D., Araujo, I., Demel, G., Klotzbach, H., Hummel, M. and Stein, H. (1997) Expression of vascular endothelial growth factor in lymphomas and Castleman disease. J Pathol, 183, pp. 44-50.
18. Hazar, B., Paydas, S., Zorludemir, S., Sahin, B. and Tuncer, I. (2003) Prognostic significance of vascular endothelial growth factor (VEGF) expression in non-Hodgkin's lymphoma. Leuk Lymphoma, 44, pp. 2089-2093.
19. Hayashibara, T., Yamada, Y., Onimura, Y., Tsutsumi, C., Nakayama, S. Mori, N. et al. (2002) Matrix metalloproteinase-9 and vascular endothelial growth factor: A possible link in adult T-cell leukemia cell invasion. Br J Haematol, 116, pp. 94-102.
20. Potti, A., Ganti, A. K., Kargas, S. and Koch, M. (2002) Immunohistochemical detection of c kit (CD117) and vascular endothelial growth factor (VEGF) overexpression in mantle cell lymphoma. Anticancer, 22, pp. 2899-2901.
21. Kini, A. R., Kay, N. E. and Peterson, L. C. (2000) Increased bone marrow angiogenesis n B-cell chronic lymphocytic leukemia. Leukemia, 14, pp. 1414-1418.
22. Vacca, A., Ribatti, D., Roncali, L. and Dammacco, F. (1995) Angiogenesis in B-cell lymphoproliferative diseases. Leuk Lymphoma, 20, pp. 27-38.
23. Crivelato, E., Nico, B., Vacca, A. and Ribatti, A. (2003) B-cell non-Hodgkin's lymphomas Express heterogeneous patterns of neovascularization. Haematologica, 88, pp. 671-678.
24. Paydas, S., Ergin, M., Erdogan, S. and Seydaoglu, G. (2008) Prognostic significance of EBV-LMP-1 and VEGF-A expressions in non-Hodgkin's lymphomas. Leuk Res, 32, pp. 1424-1430.
25. Cao, Y., Linden, P., Farnebo, J., Cao, R., Eriksson, A. Kumar, V. et al. (1998) Vascular endothelial growth factor C induces angiogenesis in vivo. Proc Natl Acad Sci USA, 95, pp. 14389-14394.
26. Streit, M. and Detman, M. (2003) Angiogenesis, lymphangiogenesis and melanoma metastasis. Oncogene, 22, pp. 3172-3179.
27. Pepper, M. S. (2001) Lymphangiogenesis and tumor metastasis. Myth or reality?. Clin Cancer Res, 7, pp. 462-468.
28. Tsuruski, T., Kanda, S., Sakai, H., Kaneteke, H., Saito, Y. Alitalo, K. et al. (1999) Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis. Br J Cancer, 80, pp. 309-313.
29. Yonemura, Y., Endo, Y., Fujita, H., Fushida, S., Ninomiya, I. Bandou, E. et al. (1999) Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin Cancer Res, 5, pp. 1823-1829.
30. Akagi, K., Ikeda, Y., Miyazaki, M., Abe, T., Kinoshita, J. Maehra, Y. et al. (2000) Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues. Br J Cancer, 83, pp. 887-891.
31. Niki, T., Iba, S., Tokunou, M., Yamada, T., Matsuno, Y. and Hirohashi, S. (2000) Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. Clin Cancer Res, 6, pp. 2431-2439.
32. Schoppman, S. F., Birner, P., Studer, P. and Breiteneder-Gelefi, S. (2001) Lymphatic microvessel density and lymphovascular invasion assessed by anti-padoplanin immunostaining in human breast cancer. Anticancer Res, 21, pp. 2351-2355.
33. Kinoshita, J., Ktamura, K., Kabashima, A., Saeki, H., Tanaka, S. and Sugimachi, K. (2001) Clinical significance of vascular endothelial growth factor-C (VEGF-C) in breast cancer. Breast Cancer Res Treat, 66, pp. 159-164.
34. Tang, R. F., Itakura, J., Aikawa, T., Matsuda, K., Fujii, H. Korc, M. et al. (2001) Overexpression of lymphangiogenesis growth factor VEGF-C in human pancreatic cancer. Pancreas, 3, pp. 285-292.
35. Yokoyama, Y., Charnock-Jones, D. S., Licence, D., Yanalhara, A., Hastingo, J. M. Holland, J. M. et al. (2003) Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian cancer. Br J Cancer, 88, pp. 237-244.
36. Hirai, M., Nakagawara, A., Oosaki, T., Hayashi, Y., Hirono, M. and Yoshihara, T. (2001) Expression of vascular endothelial growth factor (VEGF-A/VEGF-1 and VEGF-C/VEGF-2) in postmenopausal uterine endometrial carcinoma. Gynecol Oncol, 80, pp. 181-188.
37. Hoar, F. J., Chaudhri, S., Wadley, M. S. and Stonaleke, P. S. (2003) Co-expression of vascular endothelial growth factor C (VEGF-C) and c-erbB2 in human breast carcinoma. Eur J Cancer, 39, pp. 1698-1703.
38. Kurebayashi, J., Otsuki, T., Kuisue, H., Mikami, Y., Tanaka, K. Yamamoto, S. et al. (1999) Expression of vascular endothelial growth factor family members in breast cancer. Jpn J Cancer Res, 90, pp. 977-981.
39. Suzuki, K., Morita, T. and Tokue, A. (2005) Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder. Int J Urol, 12, pp. 152-158.
40. Bunone, G., Vigneri, P., Mariani, L., But, S., Collioni, P. Pilotti, S. et al. (1999) Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features. Am J Pathol, 155, pp. 1967-1976.
41. Nishida, N., Yano, H., Komai, K., Nishida, T. and Kamura, T. (2004) Vascular endothelial growth factor C and Vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma. Cancer, 101, pp. 1364-1374.
42. Neuchrist, C., Erovic, B. M., Hadisurya, A., Fischer, M. B., Steiner, G. E. Holemann, D. et al. (2003) Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck. Head Neck, 25, pp. 464-474.
43. Choi, W. W., Lewis, M. M., Lawson, D., Yin-Goen, Q., Birdsong, G. G. Cotsonis, G. A. et al. (2005) Angiogenic and lymphangiogenic microvessel density in breast carcinoma: Correlation with clinicopathologic parameters and VEGF-family gene expression. Mod Pathol, 1, pp. 143-152.
44. Kojima, M., Shiokawa, A., Ohike, N., Ohta, Y., Kato, H. Iwaku, K. et al. (2005) Clinical significance of nuclear morphometry at the invasive front of T1 colorectal cancer and relation to expression of VEGF-A and VEGF-C. Oncology, 68, pp. 230-238.
45. Salven, P., Lymbossaki, A., Heikkila, P., Sari, H. S., Enholm, B. Aase, K. et al. (1998) Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. Am J Pathol, 153, pp. 103-108.
46. Strauss, L., Volland, D., Kunkel, M. and Reichert, T. E. (2005) Dual role of VEGF family members in the pathogenesis of head and neck cancer (HNSCC): Possible link between angiogenesis and immune tolerance. Med Sci Monit, 11, pp. 280-292.
47. Muinoz-Guerra, M. F., Marazuela, E. G., Martin-Villar, E., Quintanilla, M. and Gamallo, C. (2004) Prognostic significance of intratumoral lymphangiogenesis in squamous cell carcinoma of the oral cavity. Cancer, 100, pp. 553-560.
48. Kudowaki, I., Ichinohasama, R., Harigae, H., Ishizawa, K., Okitsu, Y. Kameoka, J. et al. (2005) Accelerated lymphangiogenesis in malignant lymphoma: Possible role of VEGF-A and VEGF-C. Br J Haematol, 130, pp. 869-877.
49. Wrobel, T., Mazur, G., Dzie, P., Jelen, M., Szuba, A. Kulickowski, K. et al. (2006) Density of intranodal lymphatics and reactive lymph nodes. Folia Histochemica et Cytobiologica, 44, pp. 43-47.
50. Ganjoo, K. N., Moore, A. M., Orazi, A., Sen, J. A., Johnson, C. S. and An, C. S. (2008) The importance of angiogenesis markers in the outcome of patients with diffuse large B cell lymphoma: A retrospective study of 97 patients. J Cancer Res Clin Oncol, 134, pp. 381-387.
51. Skobe, M., Hamberg, M. L., Hawighorst, T., Schirmer, M., Wolf, G. L. Alitalo, K. et al. (2001) Concurrent induction of lymhangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am J Pathol, 159, pp. 893-903.
52. Angeli, V., Ginhoux, F., Llodra, J., Quemenuer, L., Frenette, P. S. Skobe, M. et al. (2006) B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity, 24, pp. 203-215.
53. Oh, S. J., Jeltsch, M. M., Birkenhager, R., McCarthy, J. E., Weich, H. A. Christ, B. et al. (1997) VEGF- and VEGF-C: Specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol, 188, pp. 96-109.
54. Hirakawa, S., Kodama, S., Kunstfeld, R., Kajiya, K., Brown, L. F. and Detmar, M. (2005) VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med, 201, pp. 1089-1099.
55. Dudek, A. Z., Bodempudi, V., Welsh, B. W., Jasinski, P., Griffin, R. J. Milbauer, L. et al. (2007) Systemic inhibition of tumour angiogenesis by endothelial cell-based gene therapy. Br J Cancer, 97, pp. 513-522.